AHA 2019: Results from the Treat Stroke to Target (TST) Trial — Prof Pierre Amarenco

Prof Pierre Amarenco (Paris University, Paris, FR) discuss the Benefit of a Target LDL Cholesterol Less Than 70 mg/dl After an Ischemic Stroke of Atherosclerotic Origin

Questions :
1. Why was the TST trial conducted?
2. What was design, patient population and endpoints?
3. What were your findings?
4. How should this study influence clinical practice and guidelines?
4. Will TST influence further research in this field?

Filmed on site at AHA 2019 by Radcliffe Cardiology.